North America Topical Drug Delivery Market - Industry Trends and Forecast to 2030

North America Topical Drug Delivery Market - Industry Trends and Forecast to 2030

North America Topical Drug Delivery Market, Product Type (Drug Delivery Formulations and Drug Delivery Devices), Delivery Techniques (Sonophoresis, Electroporation, Laser Ablation, Iontophoresis, Radio Frequency Ablation, Magnetophoresis, and Others), Type (Cleansing Agents, Protective Agents, Moisturizing Agents, Drying Agents, Anti-Itch Agents, Anti-Inflammatory Agents, Anti-Infective Agents, Keratolytics, and Others), Generation (First Generation Transdermal Delivery Systems, Second Generation Transdermal Delivery Systems and Third Generation Transdermal Delivery Systems), Mode of Purchase (Prescription and Over The Counter), Indication (Dermatological Disorders, Ophthalmic Disorders, Pain Management, Neurosurgical Disorders, Hormonal Therapy, Smoking Cessation and Others), Roue of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal and Others), End User (Hospitals, Speciality Centers, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030

Market Definition

Topical drug delivery is considered one of the most effective methods due to its optimal therapeutic benefits. The desired therapeutic effect and unwanted side effect of a drug are both determined by the concentration of the drug at the site of action. The concentration of the drug is determined by the dosage form and absorption of the drug at the site of action. The growth of this market is attributed to the rising prevalence of diabetes, the growing number of burn cases, escalating prevalence of dermal diseases, and technological developments in topical drug delivery systems. In addition, the major consumers of topical drug delivery systems are specialty clinics and hospitals. Some other consumers include diagnostic centers and home care centers.

Moreover, the product types of topical drug delivery systems are devices, which include transdermal gels and transdermal patches, and formulations, which include solid, semi-solid, and liquid topical formulations. The semi-solid topical formulations consider the key topical drug delivery market share in the past due to the growing number of surgical processes, including organ transplantation, where these formulations were utilized, and the escalating rate of blood donations. Gel, lotion, ointment, and cream are different types of semi-solid formulations.

Market Segmentation

The North America topical drug delivery market is categorized into nine notable segments, which are based on product type, delivery technique, type, generation, mode of purchase, indication, route of administration, end user, and distribution channel.

 On the basis of product type, the North America topical drug delivery market is segmented into drug delivery formulations and drug delivery devices

 On the basis of delivery techniques, the North America topical drug delivery market is segmented into sonophoresis, electroporation, laser ablation, iontophoresis, radio frequency ablation, magnetophoresis, and others

 On the basis of type, the North America topical drug delivery market is segmented into cleansing agents, protective agents, moisturizing agents, drying agents, anti-itch agents, anti-inflammatory agents, anti-ineffective agents, keratolytics, and others

 On the basis of generation, the North America topical drug delivery market is segmented into first generation transdermal delivery systems, second generation transdermal delivery systems, and third generation transdermal delivery systems

 On the basis of mode of purchase, the North America topical drug delivery market is segmented into prescription and over the counters

 On the basis of indication, the North America topical drug delivery market is segmented into dermatological disorders, ophthalmic disorders, pain management, neurosurgical disorders, hormonal therapy, smoking cessation, and others

 On the basis of route of administration, the North America topical drug delivery market is segmented into dermal, ophthalmic, rectal, vaginal, nasal, and others.

 On the basis of end user, the North America topical drug delivery market is segmented into hospitals, specialty centers, home healthcare, and others

 On the basis of distribution channel, the North America topical drug delivery market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others

Market Players

Some key market players in the North America topical drug delivery market are listed below:
• CRESCITA THERAPEUTICS INC.
• Cipla Inc.
• Glenmark
• Bausch Health Companies, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bayer AG
• Hisamitsu Pharmaceutical Co., Inc.
• Pfizer Inc.
• Viatris Inc.
• NITTO DENKO CORPORATION
• LTS Lohmann Therapy Systems AG
• Procter & Gamble
• ANI Pharmaceuticals, Inc.
• Medherant Limited.
• Purdue Pharmaceuticals L.P.
• AbbVie Inc.
• GSK plc.
• 3M.
• Agile Therapeutics
• Tapemark
• tesa Labtec GmbH
• Noven Pharmaceuticals, Inc.